Combined hormonal contraception (community and hospital)
Drug Safety Update
April 2008: Hormonal contraceptives: cervical cancer
February 2014: Combined hormonal contraceptives and venous thromboembolism: review confirms risk is small
March 2014: Combined hormonal contraceptives: risk of venous thromboembolism
March 2014: St John’s wort: interaction with hormonal contraceptives, including implants
Drugs in this section to be initiated in community or by sexual health provider clinics only
Contains ethinylestradiol 2.7mg + etonogestrel 11.7mg
| Pack |
|---|
| 3 system |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary